← Back to Patent Explorer
US4243582A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel glycoproteins from bovine cartilage

Assignee: Monsanto Co
•
Filing: 1979-04-26
•
Granted: 1981-01-06
•
Expires: 1999-04-26
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Two high purity glycoprotein components each having a molecular weight of about 65,000 daltons and having activity as trypsin inhibitors and inhibitors of endothelial cell growth are obtained from bovine cartilage extract. A guanidine hydrochloride extract of bovine cartilage is subjected to ammonium sulfate salt fractionation, DEAE-Sephadex ion exchange chromatography, SP-Sephadex ion exchange chromatography and Con A-Sepharose affinity chromatography to isolate these glycoproteins in a high purity preparation.

Inventors

  • 👤 Curtis A. Spilburg
  • 👤 James M. Schuck

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-24 02:24
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/81; C07K14/8107; C07K14/811; Y; Y10; Y10S; Y10S530/00; Y10S530/827; Y10S530/84

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 151 words
A high purity glycoprotein isolated from bovine cartilage selected from the group consisting of Component A and Component B and having the following characteristics: (a) amino acid composition as follows: ______________________________________ Number of Residues Amino Acid Component A Component B ______________________________________ LYS 25 19 HIS 10 9 ARG 13 12 ASP 39 35 THR 23 20 SER 31 24 GLU 47 40 PRO 28 23 GLY 22 19 ALA 34 28 1/2 CYS 10 4 VAL 31 27 MET 5 4 ILE 15 14 LEU 37 35 TYR 10 8 PHE 16 15 ______________________________________ said number of residues for each amino acid being subject to a variation of about±10% from the number stated; (b) carbohydrate composition comprising hexose, fucose, sialic acid and hexosamine; (c) molecular weight of about 65,000±10,000; (d) isoelectric point of about 3.8; and (e) having activity as an inhibitor of endothelial cell growth and as a trypsin inhibitor.
Claim 2
Dependent Claim 151 words
A high purity glycoprotein isolated from bovine cartilage selected from the group consisting of Component A and Component B and having the following characteristics: (a) amino acid composition as follows: ______________________________________ Number of Residues Amino Acid Component A Component B ______________________________________ LYS 25 19 HIS 10 9 ARG 13 12 ASP 39 35 THR 23 20 SER 31 24 GLU 47 40 PRO 28 23 GLY 22 19 ALA 34 28 1/2 CYS 10 4 VAL 31 27 MET 5 4 ILE 15 14 LEU 37 35 TYR 10 8 PHE 16 15 ______________________________________ said number of residues for each amino acid being subject to a variation of about±10% from the number stated; (b) carbohydrate composition comprising hexose, fucose, sialic acid and hexosamine; (c) molecular weight of about 65,000±10,000; (d) isoelectric point of about 3.8; and (e) having activity as an inhibitor of endothelial cell growth and as a trypsin inhibitor.
Claim 3
Dependent Claim 58 words
A process of preparing the glycoproteins of claim 1 comprising the steps of (a) fractionating a guanadine .HCl extract of bovine cartilage with 40-80% ammonium sulfate; (b) adsorbing the fractionated substance with DEAE-Sephadex ion exchanger and desorbing by elution; (c) passing the eluate over SP-Sephadex ion exchanger; (d) passing over Con A-Sepharose; and (e) recovering the glycoproteins therefrom.
Claim 4
Dependent Claim 96 words
A process for preparing the glycoproteins of claim 1 comprising the steps of (a) fractionating a guanidine .HCl extract of bovine cartilage with 40-80% ammonium sulfate; (b) adsorbing the fractionated substance with DEAE-Sephadex ion exchanger in about 0.01 M NaCl, buffered at about pH 8.0, and desorbing by eluting with a substantially linear salt gradient to about 0.25 M NaCl; (c) passing the eluate over SP-Sephadex in about 50 mM sodium acetate, about pH 5.0; (d) passing over Con A-Sepharose in about 0.5 M NaCl, buffered at about pH 6.7; and (e) recovering the glycoproteins therefrom.

References Cited (Backward Citations)

US4190573A Cited
US4108849A Cited
US4002572A Cited
US4042457A Cited
US4154821A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-01-06 1984-07-07 1985-01-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-01-06 1988-07-07 1989-01-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-01-06 1992-07-07 1993-01-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag